Abstract:Polymeric micelles (PMs) have been used to improve the poor aqueous solubility, slow absorption and non-selective biodistribution of chemotherapeutic agents (CAs), albeit, they suffer from disassembly and premature release of payloads in the bloodstream. To alleviate the thermodynamic instability of PMs, different core crosslinking approaches were employed. Herein, we synthesized the poly(ethylene oxide)-b-poly((2-aminoethyl)diselanyl)ethyl l-aspartamide)-b-polycaprolactone (mPEG-P(LA-DSeDEA)-PCL) copolymer which self-assembled into monodispersed nanoscale, 156.57 ± 4.42 nm, core crosslinked micelles (CCMs) through visible light-induced diselenide metathesis reaction between the pendant selenocystamine moieties. The CCMs demonstrated desirable doxorubicin (DOX)-loading content (7.31%) and encapsulation efficiency (42.73%). Both blank and DOX-loaded CCMs (DOX@CCMs) established appreciable colloidal stability in the presence of bovine serum albumin (BSA). The DOX@CCMs showed redox-responsive drug releasing behavior when treated with 5 and 10 mM reduced glutathione (GSH) and 0.1% H2O2. Unlike the DOX-loaded non-crosslinked micelles (DOX@NCMs) which exhibited initial burst release, DOX@CCMs demonstrated a sustained release profile in vitro where 71.7% of the encapsulated DOX was released within 72 h. In addition, the in vitro fluorescent microscope images and flow cytometry analysis confirmed the efficient cellular internalization of DOX@CCMs. The in vitro cytotoxicity test on HaCaT, MDCK, and HeLa cell lines reiterated the cytocompatibility (≥82% cell viability) of the mPEG-P(LA-DSeDEA)-PCL copolymer and DOX@CCMs selectively inhibit the viabilities of 48.85% of HeLa cells as compared to 15.75% of HaCaT and 7.85% of MDCK cells at a maximum dose of 10 μg/mL. Overall, all these appealing attributes make CCMs desirable as nanocarriers for the delivery and controlled release of DOX in tumor cells.

Controllable Fabrication and Characterization of Biocompatible Core-Shell Particles and Hollow Capsules As Drug Carrier

Preparation and Biological Characterization of Hollow Magnetic Fe3O4@C Nanoparticles As Drug Carriers with High Drug Loading Capability, Ph-Control Drug Release and MRI Properties

Hollow Polyelectrolyte Microcapsules As Advanced Drug Delivery Carriers

Fabrication of ferromagnetic carbon hollow capsules for drug carriers

Drug Co-Loading and Ph-Sensitive Release Core–shell Nanoparticles Via Layer-by-layer Assembly

Core-Shell Structure Design of Hollow Mesoporous Silica Nanospheres Based on Thermo-Sensitive PNIPAM and pH-Responsive Catechol-Fe3+ Complex

Fabrication of Core Crosslinked Polymeric Micelles as Nanocarriers for Doxorubicin Delivery: Self-Assembly, In Situ Diselenide Metathesis and Redox-Responsive Drug Release

Multifunctional SiO2@Gd2O3:Yb/Tm hollow capsules: controllable synthesis and drug release properties

Synthesis of Discrete and Dispersible Hollow Mesoporous Silica Nanoparticles with Tailored Shell Thickness for Controlled Drug Release

Facile Synthesis of Ph Sensitive Polymer-Coated Mesoporous Silica Nanoparticles and Their Application in Drug Delivery

Core–shell SrTiO3:Yb3+,Er3+@mSiO2 nanoparticles for controlled and monitored doxorubicin delivery

Thermo and Ph Dual Responsive, Polymer Shell Coated, Magnetic Mesoporous Silica Nanoparticles for Controlled Drug Release

Self-Assembly of Biocompatible Core-Shell Nanocapsules with Tunable Surface Functionality by Microfluidics for Enhanced Drug Delivery

Self-assembled multifunctional core-shell highly porous metal-organic framework nanoparticles

Polyelectrolyte Microcapsules Templated on Poly(styrene Sulfonate)-Doped CaCO3 Particles for Loading and Sustained Release of Daunorubicin and Doxorubicin

Composite Core-Shell Microparticles from Microfluidics for Synergistic Drug Delivery

Direct Surface Grafting of Mesoporous Silica Nanoparticles with Phospholipid Choline-Containing Copolymers Through Chain Transfer Free Radical Polymerization and Their Controlled Drug Delivery

Ultrasound, pH, and magnetically responsive crown-ether-coated core/shell nanoparticles as drug encapsulation and release systems.

Silica Composite Nanoparticles Containing Fluorescent Solid Core and Mesoporous Shell with Different Thickness As Drug Carrier

Redox- and Temperature-Controlled Drug Release from Hollow Mesoporous Silica Nanoparticles.

Preparation and Characterization of Liposomes-containing Polyelectrolyte Microcapsules as Drug Carriers